Cisbio Bioassays and Orion Diagnostica Oy Sign an Agreement for Steroid Radioimmunoassays

Mon, 10/07/2013 - 6:00pm
Business Wire

Cisbio Bioassays, global developer of in vitro diagnostic kits and of products and services used in drug discovery, and Orion Diagnostica Oy, an in vitro diagnostics company specializing in development, production and sales of diagnostic test systems, announced that they have signed an agreement covering raw materials and related documentation for the manufacturing of ultrasensitive Estradiol, Cortisol and Testosterone radioimmunoassays. Cisbio Bioassays plans to start the manufacturing and worldwide marketing of products based on these assets in 2014. Until then, the assays concerned remain available from Orion Diagnostica Oy, under the brand name Spectria.

“These assays demand the high quality manufacturing standards which Cisbio Bioassays sets for its radioimmunoassay production. Adding them to our range will strengthen our leadership in this field“ said Berthold Baldus, President, Cisbio Bioassays. “This will undeniably facilitate access to a more complete assay offering for our customer network worldwide".

“We are delighted that through this arrangement Orion Diagnostica Oy’s long term global customers for Spectria radioimmunoassay will have a possibility for continuation with products manufactured by our long term partner.” Jaakko Rissanen, President, Orion Diagnostica Oy said.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.